This is a preview of subscription content, log in via an institution to check access.
Reference
Fenaux P, et al. Efficacy and safety of imetelstat in rbc transfusion-dependent (TD) IPSS Low/Int-1 MDS relapsed/refractory to erythropoiesis-stimulating agents (ESA) (IMerge). Blood 130 (Suppl. 1): 4256, 07 Dec 2017 [abstract] -France
Rights and permissions
About this article
Cite this article
Imetelstat. Reactions Weekly 1695, 211 (2018). https://doi.org/10.1007/s40278-018-44038-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-018-44038-1